Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
INDUSTRY
×
Hypopharyngeal Neoplasms
×
Clear all
Filters
3
NCT06295731
2026-03-31
HexAgon-HN
Inhibrx Biosciences, Inc
Phase 2/3
Active not recruiting
410 enrolled